Ligand Pharmaceuticals, Inc. (LGNDZ) Stock Overview
Explore Ligand Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Ligand Pharmaceuticals, Inc. (LGNDZ)
Key Financials
Key Financials
Market Cap
26.1K
P/E Ratio
0.00
EPS (TTM)
N/A
ROE
0.16%
LGNDZ Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Ligand Pharmaceuticals, Inc. (LGNDZ) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 39.15, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 0.00 and a market capitalization of 26.1K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.